Another Option for Hypoactive Sexual Desire

Open Access
Publisher Website
Google Scholar
Abstract
The FDA recently approved bremelanotide for acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It’s the first “as-needed” tre